Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...

Vertex Pharmaceuticals chief Reshma Kewalramani said AI could reduce the time spent on drug-approval paperwork from months to ...

Watch as leftover hardwood offcuts are transformed into a vibrant swirly hollow form on the lathe. With epoxy resin enhancing ...

Particles as different as soap bubbles and ball bearings can be made to arrange themselves in exactly the same way, according ...

With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...

Many are guilty to making this common pushup mistake. Here's a simple way to fix it and make your pushups more efficient.

This study presents a phase-field crystal model that simulates AB-BA transitions in bilayer graphene, highlighting defect ...

These questions come from my Udemy training and the certificationexams.pro website, resources that have helped many students pass the DP-100 certification. These are not DP-100 exam dumps or ...

Worldwide Healthcare Trust PLC - Half-year Financial Report PR Newswire LONDON, United Kingdom, November 13 LONDON STOCK EXCHANGE ANNOUNCEMENT Worldwide ...

Focused U.S. Small Cap Active ETF gained (gross of fees) but underperformed the Russell 2000 Index. Read more here.

Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi therapeutic ...

Two South Dakota advocacy groups requested board members amend the standards: the South Dakota Chapter of the Alzheimer’s ...